Form 4 Filing for ADIAL PHARMACEUTICALS, INC.

This filing details a Form 4 submission for ADIAL PHARMACEUTICALS, INC. concerning the reporting owner, Vinay Shah, Chief Financial Officer. On April 7, 2026, Mr. Shah was granted 17,325 restricted shares of common stock. These shares vest in full on the earlier of the one-year anniversary of the grant date or a Change of Control, provided Mr. Shah remains in continuous service. The transaction code is "A" for acquisition, with a per-share price of $0.00, indicating a grant rather than a purchase. Following this transaction, Mr. Shah directly owns 17,325 shares. The filing is signed by John Martin as attorney-in-fact for Vinay Shah, with a signature date of April 9, 2026.